6 -
Forfeitures, Suspensions, Illegal or Ineligible Players, Tribunal, Penalties
& Anti-doping
IHA & IHNSW Anti-Doping Policy
Consequent to IHA membership of the ASC, the AOC and
the IIHF, IHNSW condemns the use of performance enhancing drugs
and doping practices in the sport of Ice Hockey. The IHA Prohibitive
Substance Policy applies to all of its members including players,
officials, administrators, coaches, referees, office bearers and
employees and lists a wide variety of banned substances that, following
a positive test result, may result in a predetermined suspension or
ban being imposed.
The list includes some medications that will not be
tolerated under any circumstances whether essential to an individual's
well being or not and in which case, a physician should be advised
and an alternative, permissible drug prescribed.
The Australian Sports Anti-Doping Agency (ASADA), is
the national drug testing authority empowered to conduct random
testing of athletes for the detection of prohibited substances.
To ensure that its members conform to these requirements, IHA has
implemented the following procedures, which must be strictly adhered
to:
-
At the time of registration,
or at the time of prescribing medication after registration, a letter
from the physician must be supplied to the club secretary detailing
the drug/substance prescribed and the reasons for its
prescription.
-
The club secretary must retain a copy of such letters
and send the original to the IHNSW office. The dates of receipt
and forwarding should also be recorded.
-
Upon receipt of notification, IHNSW will record
the member's name in a register and forward copies of the notification
to IHA, ASADA and the AOC. The original letter is to be kept by
IHNSW and all pertinent dates recorded.
-
The member will subsequently be advised of the dates
of official notification was sent to IHA, ASADA and the AOC.
Although testing is normally aimed at athletes competing
at national or international level, the IIHF and ASADA have implemented
unannounced dope testing that can be administered anywhere, anytime.
Note:
Cannabis can be detected in the blood stream
6 months later.
Any medication must be supported by a current medical
certificate.